|Bid||15.11 x 1100|
|Ask||16.08 x 800|
|Day's Range||15.03 - 16.58|
|52 Week Range||11.70 - 65.00|
|Beta (5Y Monthly)||2.80|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 08, 2022 - Aug 12, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||55.55|
Subscribe to Yahoo Finance Plus to view Fair Value for ARCT
SAN DIEGO, June 22, 2022--Arcturus Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
The latest analyst coverage could presage a bad day for Arcturus Therapeutics Holdings Inc. ( NASDAQ:ARCT ), with the...